Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9000+0.2800 (+7.73%)
At close: 04:00PM EDT
3.9000 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Immunovant to Present at the UBS Global Healthcare Conference on May 23rd

    NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at the UBS Global Healthcare Conference, taking place May 23rd-25th, 2022. UBS Global Healthcare Conference fireside chat details: Date: Monday, May 23rd, 2022Time: 1:15pm Eastern Time Webcast: The presentati

  • GlobeNewswire

    Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th

    NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at LifeSci Partners’ virtual Immunology and Inflammation (I&I) Symposium, taking place May 10th-11th, 2022. LifeSci Partners Immunology and Inflammation Symposium fireside chat details: Date:Tuesday, May 10th

  • Simply Wall St.

    Companies Like Immunovant (NASDAQ:IMVT) Are In A Position To Invest In Growth

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...